Reduced hemoglobin and increased C-reactive protein are associated with upper gastrointestinal bleeding

Minoru Tomizawa1, Fuminobu Shinozaki1, Rumiko Hasegawa1

  • 1Minoru Tomizawa, Department of Gastroenterology, National Hospital Organization Shimoshizu Hospital, Yotsukaido City, Chiba 284-0003, Japan.

Insights

Early upper gastrointestinal endoscopy aids in identifying bleeding risks. Key predictors include low hemoglobin and elevated C-reactive protein levels, indicating potential gastrointestinal bleeding.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Diagnostic Medicine

Background:

  • Upper gastrointestinal (GI) bleeding is a significant clinical concern.
  • Early detection and intervention are crucial for reducing mortality associated with GI bleeding.

Purpose of the Study:

  • To evaluate the predictive value of hemoglobin (Hb) and C-reactive protein (CRP) levels for upper GI bleeding.
  • To determine if changes in Hb and CRP can predict the occurrence of upper GI bleeding.

Main Methods:

  • Patients with upper GI bleeding were classified using the Forrest classification.
  • Hemoglobin (Hb) and C-reactive protein (CRP) levels were measured around the time of endoscopy and 3 months prior.
  • The rate of change in Hb and CRP was calculated to assess temporal trends.

Main Results:

  • Hemoglobin levels below 11.7 g/dL showed high sensitivity (94.1%) and specificity (77.1%) for predicting upper GI bleeding.
  • A reduction rate in Hb greater than 21.3% and an increase in CRP greater than 100% were significant predictors.
  • The rate of change in CRP demonstrated high predictive accuracy (AUC 0.901).

Conclusions:

  • Hemoglobin levels < 11.7 g/dL are indicative of upper GI bleeding risk.
  • A significant decrease in Hb (>21.3%) or a substantial increase in CRP (>100%) within 3 months prior to endoscopy are strong predictors.
  • These biochemical markers can aid in the early identification of patients at risk for upper GI bleeding.
Abstract

Related Concept Videos

Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.2K
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
28
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.7K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K